{"entity":{"id":"nct06840483","kind":"trial","name":"Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer","aka":[],"tldr":"A phase 2 trial of Zelenectide pevedotin in advanced solid tumours, run by BicycleTx Limited, active and no longer recruiting.","summary":"Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer is a phase 2 interventional study registered as NCT06840483 by BicycleTx Limited, with 66 participants enrolled, started 2025-03-03 and due to reach its primary completion in 2028-06-30. Interventions recorded: Zelenectide pevedotin (BT8009).","status":"active","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06840483","url":"https://clinicaltrials.gov/study/NCT06840483"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":["peptide-drug-conjugate"],"targets":[],"drugs":["zelenectide-pevedotin"],"companies":["bicycle-therapeutics"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06840483","phase":"2","setting":"Phase 2 Study of Zelenectide Pevedotin in Participants With NECTIN4 Amplified Advanced Breast Cancer","sponsor":"BicycleTx Limited","started":"2025-03-03","startedType":"actual","enrolled":66,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06840483/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"technology":[{"id":"peptide-drug-conjugate","kind":"technology","name":"Peptide-drug & small-molecule-drug conjugates","route":"/technologies/peptide-drug-conjugate/"}],"drug":[{"id":"zelenectide-pevedotin","kind":"drug","name":"Zelenectide pevedotin","route":"/drugs/zelenectide-pevedotin/"}],"company":[{"id":"bicycle-therapeutics","kind":"company","name":"Bicycle Therapeutics","route":"/companies/bicycle-therapeutics/"}]}}